Clinical Trial Update: Prospective Study of UDP-gluconoryltransferase 2B17 Genotype as a Predictive Marker of Exemestane PK and PD [NA]

View source ↗

Summary

A prospective clinical trial update evaluating whether UDP-glucuronosyltransferase 2B17 genotype can predict exemestane pharmacokinetics and pharmacodynamics in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Exemestane (Exemestane)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Breast Carcinoma | NA | Status: UNKNOWN